SL-28 / Second Life Therapeutics - LARVOL DELTA

SL-28 for Advanced Solid Tumours (clinicaltrials.gov) - P1/2 | N=60 | Not yet recruiting | Sponsor: Second Life Therapeutics

New P1/2 trial • Bladder Cancer • Breast Cancer • Colorectal Cancer • Endometrial Cancer • Esophageal Cancer • Gastric Cancer • Gastrointestinal Cancer • Genetic Disorders • Genito-urinary Cancer • Head and Neck Cancer • Hormone Receptor Positive Breast Cancer • Kidney Cancer • Liver Cancer • Lung Adenocarcinoma • Lung Cancer • Melanoma • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Pancreatic Adenocarcinoma • Pancreatic Cancer • Prostate Cancer • Renal Cell Carcinoma • Skin Cancer • Small Cell Lung Cancer • Solid Tumor • Squamous Cell Carcinoma of Head and Neck